16 results
6-K
EX-99.1
CNTB
Connect Biopharma Holdings Ltd
21 Nov 23
Exclusive License and Collaboration Agreement
6:13am
determines that an event, incident or circumstance has occurred that may result in the need for a recall or market withdrawal in the Territory … similar action in connection with the Licensed Compound or Licensed Product or in the event Licensor determines that an event, incident
F-3
EX-1.2
CNTB
Connect Biopharma Holdings Ltd
15 Apr 22
Shelf registration (foreign)
5:27pm
with the provisions of Section 11 hereunder, will pay all expenses incident to the performance of its obligations hereunder, including expenses
20-F
2021 FY
CNTB
Connect Biopharma Holdings Ltd
31 Mar 22
Annual report (foreign)
4:33pm
revenues, and other obligations incident to doing business in another country;
foreign reimbursement, pricing and insurance regimes;
difficulty … of potential loss, if any, that could result therefrom. If we cannot successfully resolve a security incident or contain any potential loss, it could
6-K
EX-99.2
cardtda05axsfp6o0 78
31 Aug 21
Index to the Unaudited Interim Condensed Consolidated Financial Statements
4:16pm
6-K
EX-99.1
rfmjjk 9kt
31 Aug 21
Index to the Unaudited Interim Condensed Consolidated Financial Statements
4:16pm
424B4
cfcp6fon9u
19 Mar 21
Prospectus supplement with pricing info
4:49pm
F-1/A
9tgu 6jj7
18 Mar 21
Registration statement (foreign) (amended)
6:15am
F-1/A
1yprn6afg0cnjnv
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-1/A
EX-1.1
gt3ikc
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-1
EX-10.1
j7kfbjpcyo
26 Feb 21
Registration statement (foreign)
4:56pm
F-1
5gure
26 Feb 21
Registration statement (foreign)
4:56pm
DRS/A
354mo 1g280btz7pzrf
26 Jan 21
Draft registration statement (amended)
12:00am
DRS
q3l4bf8 y1
17 Dec 20
Draft registration statement
12:00am
DRS
EX-10.1
2mn3y88 yac8k
17 Dec 20
Draft registration statement
12:00am
- Prev
- 1
- Next